IL-16 is found to be secreted from MS patient-derived cytotoxic T lymphocytes (CTLs) when stimulated with the myelin-specific antigen proteolipid protein, suggesting a role for IL-16 in MS disease [17]. Here, IL16 is linked to myeloid sarcoma.